Jinyu Bio-technology Co.

Jinyu Bio-technology Co. was founded in 1993 and is the largest animal vaccine company in China. Jinyu has a complete portfolio for animal vaccines, which includes ruminants, swine and poultry. It is the leading manufacturer of FMD vaccines in China. Jinyu is also one of the few Chinese animal health companies whose products meet international standards. The firm was selected as the 2016 Best Company in Asia and Australasia by Animal Pharm. Jinyu exported vaccines to a number of countries such as Mongolia, Bangladesh and Egypt. Jinyu's average annual sales growth rate has been over 30% since 2012. In the most recent financial year, Jinyu recorded 17% sales growth with a 38% net profit margin. Jinyu has China's uniquely designated national animal vaccine engineering lab, BSL-3 lab and animal facilities, where it develops its pipeline of advanced animal vaccines. Jinyu is also currently constructing a new biological science and technology industrial park in Hohhot that is scheduled to open in 2018. The Jinyu International Biotechnology Industrial Park covers an area of 110 acres and has planned a US$363 million investment for phase one to build up an animal vaccine production and R&D base. By recognizing innovations as its core competitiveness and a strong engine for growth, Jinyu visions to lead the China animal health industry by expanding international markets in the next five years.